BD85810
Naše společnost BD Česká republika
The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. BD Medical’s Consulting services are primarily targeted at hospitals, healthcare systems and networks of healthcare providers.citation needed
- BD stated that the use of the affected devices may cause an air embolism or leakage of blood and/or therapy, which may result in serious injury or death.
- Designed and validated for use with cell suspensions, whole blood and tissue pieces.
- In April 2016, the Occupational Safety and Health Administration fined BD US$112,700 for safety violations.
- The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson.
- The approximately 2.8 million BD Q-Syte and 2.9 million BD Nexiva units containing 5 million BD Q-Syte devices that were recalled were distributed in the United States, Asia, Canada, Europe, Mexico, the Middle East, South Africa, and South America.
They found repeat and serious violations of health and safety law that had resulted in two employees having partial finger amputations. The name “embecta” represents the company’s commitment to people living with diabetes and its corporate heritage, with the “em-” prefix evoking empathy for people living with diabetes and the empowerment of the new company and the “bect” imbibed from Becton. Embecta Corporation is a standalone public company focused on diabetes care.
Use a variety of training courses for instruments and applications to take full advantage of the capabilities of BD products. Explore our webinar series spanning a broad range of topics and in-depth reviews by senior scientists, professionals and clinicians. Search or filter to find and learn more about the panels. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsody™ single-cell platform. The BD Rhapsody™ single-cell platform has been a key tool for the publication of our clinical research. Designed and validated for use with cell suspensions, whole blood and tissue pieces.
Health and safety issues
BD Horizon RealViolet™ 544 Reagents offer limited spillover, robust intracellular performance and lot-to-lot consistency. BD announced that it notified customers about the recall by letter and has bd-e2bet.com/login/ been working with the U.S. The recall was initiated on Oct. 28, 2009 after BD received complaints of problems due to air entry through a part of the device. BD stated that the use of the affected devices may cause an air embolism or leakage of blood and/or therapy, which may result in serious injury or death.
BD Horizon RealBlue™ 705 Reagents
Get expert-level panel design support and up to a 50% discount on your panel through the BD PRIMER Program In March 2021 BD announced a recall of infusion sets for CC, GP, VP, GW/GW800, SE, and IVAC 590 Alaris Pumps and gravity infusion sets and connectors following the news that a supplier falsified sterilisation documents going back ten years. Food and Drug Administration and worldwide health agencies to coordinate recall activities. The approximately 2.8 million BD Q-Syte and 2.9 million BD Nexiva units containing 5 million BD Q-Syte devices that were recalled were distributed in the United States, Asia, Canada, Europe, Mexico, the Middle East, South Africa, and South America. BD recalled and tested the syringes in question, and revealed sterile particulates in 0.013 percent of the products.
In February 2010 BD announced a voluntary product recall of certain lots of BD Q-Syte Luer Access Devices and BD Nexiva Closed IV Catheter Systems. In April 2016, the Occupational Safety and Health Administration fined BD US$112,700 for safety violations. The company’s line of plastic conical screwtop test tubes, known as ‘Falcon tubes’, is popular and the term is sometimes used as a generic term for such tubes. In certain places, BD Medical also offers consulting and analytics related services.
Health and safety issues
A unique ecosystem to collaborate on flow cytometry panel design, improve cytometer efficiency and manage your laboratory. An interactive tool containing key cell information to help plan your flow cytometry experiments. Fill out the form to receive updates on our latest products and innovations, exclusive promotions, educational tours, and other exciting news. Backed by cutting-edge technology and more than 50 years of flow cytometry expertise
2 ukupno pregleda, 2 danas